scholarly article | Q13442814 |
P2093 | author name string | Hideyuki Takahashi | |
Haruo Watanabe | |||
Shinji Saito | |||
Motohiro Matsuura | |||
Kazuyoshi Kawahara | |||
P2860 | cites work | Factors promoting acute and chronic diseases caused by yersiniae | Q36637747 |
Yersinia pestis type III secretion system-dependent inhibition of human polymorphonuclear leukocyte function | Q36804172 | ||
Synthetic lipid A with endotoxic and related biological activities comparable to those of a natural lipid A from an Escherichia coli re-mutant | Q37051385 | ||
Effects of Psa and F1 on the adhesive and invasive interactions of Yersinia pestis with human respiratory tract epithelial cells | Q38484199 | ||
Activity of monosaccharide lipid A analogues in human monocytic cells as agonists or antagonists of bacterial lipopolysaccharide. | Q39513148 | ||
Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis | Q39654111 | ||
Bacterial endotoxins: extraordinary lipids that activate eucaryotic signal transduction | Q39936881 | ||
The pH 6 antigen is an antiphagocytic factor produced by Yersinia pestis independent of Yersinia outer proteins and capsule antigen | Q40421231 | ||
Regulatory roles for CD14 and phosphatidylinositol in the signaling via toll-like receptor 4-MD-2. | Q40903298 | ||
Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response | Q41452286 | ||
Transmission of Yersinia pestis from an infectious biofilm in the flea vector | Q41461840 | ||
A rapid and simple microfluorometric phagocytosis assay | Q41548176 | ||
Preparation and properties of a standardized lipopolysaccharide from salmonella abortus equi (Novo-Pyrexal) | Q41658578 | ||
Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes | Q41660884 | ||
Structural requirements of lipid A responsible for the functions: a study with chemically synthesized lipid A and its analogues. | Q54659769 | ||
Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. | Q55033421 | ||
Lipid A modification systems in gram-negative bacteria | Q24650951 | ||
Lipopolysaccharide endotoxins | Q24650970 | ||
Yersinia pestis--etiologic agent of plague | Q29619320 | ||
Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes | Q29619621 | ||
Modification of the structure and activity of lipid A in Yersinia pestis lipopolysaccharide by growth temperature | Q30836915 | ||
A triple mutant of Escherichia coli lacking secondary acyl chains on lipid A. | Q31037616 | ||
Variation in lipid A structure in the pathogenic yersiniae | Q31067117 | ||
Structural analysis of Francisella tularensis lipopolysaccharide. | Q31120898 | ||
Novel modification of lipid A of Francisella tularensis | Q33206138 | ||
A comprehensive transposon mutant library of Francisella novicida, a bioweapon surrogate | Q33268806 | ||
Yersinia pestis is viable with endotoxin composed of only lipid A. | Q34048402 | ||
Role of Yersinia murine toxin in survival of Yersinia pestis in the midgut of the flea vector | Q34125533 | ||
Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis | Q34413354 | ||
Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities | Q34668829 | ||
Administration of a synthetic TLR4 agonist protects mice from pneumonic tularemia. | Q34714290 | ||
Lack of in vitro and in vivo recognition of Francisella tularensis subspecies lipopolysaccharide by Toll-like receptors | Q35220354 | ||
Intraspecific diversity of Yersinia pestis. | Q35745842 | ||
Intracellular survival mechanisms of Francisella tularensis, a stealth pathogen. | Q36292504 | ||
Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor beta1 and beta2 chain expression | Q36367736 | ||
P433 | issue | 1 | |
P921 | main subject | Yersinia pestis | Q153875 |
lipopolysaccharide | Q421804 | ||
P304 | page(s) | 49-55 | |
P577 | publication date | 2009-11-04 | |
P1433 | published in | Clinical and Vaccine Immunology | Q5133811 |
P1476 | title | Immunomodulatory effects of Yersinia pestis lipopolysaccharides on human macrophages | |
P478 | volume | 17 |
Q33771536 | An avirulent Burkholderia pseudomallei ∆purM strain with atypical type B LPS: expansion of the toolkit for biosafe studies of melioidosis |
Q40293226 | Evasion of human innate immunity without antagonizing TLR4 by mutant Salmonella enterica serovar Typhimurium having penta-acylated lipid A. |
Q38113080 | Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis. |
Q38008395 | Host Defense and the Airway Epithelium: Frontline Responses That Protect against Bacterial Invasion and Pneumonia |
Q61802943 | Inflammasomes, Autophagy, and Cell Death: The Trinity of Innate Host Defense against Intracellular Bacteria |
Q38059703 | Lipopolysaccharide of Yersinia pestis, the Cause of Plague: Structure, Genetics, Biological Properties |
Q28608164 | Lipopolysaccharides from Commensal and Opportunistic Bacteria: Characterization and Response of the Immune System of the Host Sponge Suberites domuncula |
Q89878357 | Protection and Safety Evaluation of Live Constructions Derived from the Pgm- and pPCP1- Yersinia pestis Strain |
Q54330361 | Pseudoalteromonas strains are potent immunomodulators owing to low-stimulatory LPS. |
Q40995016 | Structural Modifications of Bacterial Lipopolysaccharide that Facilitate Gram-Negative Bacteria Evasion of Host Innate Immunity |
Q36357954 | Structural diversity of Burkholderia pseudomallei lipopolysaccharides affects innate immune signaling |
Q38647533 | The Characteristics and Function of Bacterial Lipopolysaccharides and Their Endotoxic Potential in Humans |
Search more.